Exchange of Contracts at Saffron Walden, Essex

RNS Number : 2826J
Barkby Group PLC
26 April 2022

26 April 2022

Barkby Group PLC

("Barkby" or the "Company")


Exchange of Contracts at Saffron Walden, Essex

Barkby Group PLC is pleased to announce it has unconditionally exchanged contracts to sell its site at Saffron Walden for £3.45m.  Barkby currently has a book value of £1m for the site, the sale will result in a net profit of £2.3m for Barkby after disposal costs.

Completion has been agreed for 31st May 2022.

Charles Dickson, Executive Chairman of Barkby Group Plc, commented: 

"I am delighted to have exchanged contracts for the sale of the site. Barkby has added significant value to the site through a series of successful planning applications which has resulted in a significant profit for shareholders."


Barkby Group plc

Charles Dickson (Executive Chairman)

Douglas Benzie (CFO)


via Camarco

finnCap Ltd (Nomad and Broker)

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)


+44 (0) 20 7220 0500

Camarco (Financial PR)

Jennifer Renwick/Phoebe Pugh

+44 (0) 20 3757 4994


About The Barkby Group Plc:


Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).

 Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.




This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings